Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novamind Inc
(OP:
NVMDF
)
N/A
UNCHANGED
Last Price
Updated: 3:36 PM EDT, Jun 13, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novamind Inc
< Previous
1
2
3
Next >
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
November 22, 2022
Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness Corp., has entered into a joint venture agreement with Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience...
Via
Benzinga
EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental
July 18, 2022
Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine...
Via
Benzinga
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
June 15, 2022
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.
Via
Benzinga
New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval
June 09, 2022
Numinus Wellness Inc.
Via
Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
April 12, 2022
Via
Benzinga
Novamind Expands To Arizona With Purchase Of New Ketamine Clinic
December 23, 2021
Novamind Inc. (Canadian: NM) (OTCQB:NVMDF...
Via
Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.
Via
Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
May 19, 2022
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.
Via
Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
May 17, 2022
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.
Via
Benzinga
Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders
May 11, 2022
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).
Via
Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
May 02, 2022
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Via
Benzinga
Novamind To Offer Virtual Mental Health Therapy Sessions
May 02, 2022
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit
Via
Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
April 13, 2022
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.
Via
Benzinga
Core One Labs Begins Trading On OTCQB
April 06, 2022
Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB: CLABF) started trading on the OTCQB Venture ...
Via
Benzinga
EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co.
March 29, 2022
Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of...
Via
Benzinga
Novamind To Offer Psychedelic-Assisted Group Therapy
March 24, 2022
Novamind Inc. (OTCQB: NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups ...
Via
Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
March 22, 2022
The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations.
Via
Benzinga
Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment
March 16, 2022
Novamind Inc. (OTCQB: NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ: MNMD)(NEO:MMED) to host ...
Via
Benzinga
Novamind Begins Clinical Trial Of Psilocybin For Depression
March 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
March 15, 2022
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ...
Via
Benzinga
Novamind Stock Slightly Up On Grants Restricted Share Units
March 11, 2022
Novamind Inc. (OTCQB: NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an ...
Via
Benzinga
Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder
March 09, 2022
Novamind Inc. (OTCQB: NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major ...
Via
Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
March 09, 2022
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...
Via
Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
March 07, 2022
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ...
Via
Benzinga
Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ
March 02, 2022
Psychedelics-focused mental health company Novamind Inc. (CSE:NM
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...
Via
Benzinga
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
February 07, 2022
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE.
Via
Benzinga
Cancer Patients' Case To Use Psilocybin Under Right To Try Law Dismissed By Fed Appeals Court
February 01, 2022
As the psychedelics space gains traction on many levels, a number of studies are being conducted to examine whether psychedelic medications can or should be used to treat depression in cancer...
Via
Benzinga
Novamind Stock Dives On $3.95M Private Placement With Institutional Investor
January 24, 2022
Novamind Inc. (CSE:NM) (OTCQB:
Via
Benzinga
The Year In Review For Psychedelic Drug Stocks: 2021
December 21, 2021
2021 was two different
Via
Talk Markets
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.